🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It was a privilege to share and moderate a great case presentation by Sera Satoi MD 里井セラ🩺日本人女性初米国消化器内科医 at #LiverRounds with Northeast Ohio Liver Alliance. There was a great turnout of hepatologists, fellows, and residents. University Hospitals CWRU-GI/Case Western GI Fellowship Case Western/UH IM Chiefs

This narrative review was truly a multidisciplinary, multi-institutional effort covering liver-directed therapies for #HCC. journals.lww.com/hepcomm/fullte…

📑 Comparative effectiveness of different #corticosteroid regimens in severe #alcohol-associated hepatitis‼️ ❌ difference in 30-day ☠️ between prednisolone, prednisone, or methylprednisolone journals.lww.com/hepcomm/fullte…

Great consensus statement about de novo malignancy screening after liver transplant. It also reviews management of immunosuppression with de novo malignancies, including mTOR inhibitors. #livertwitter #gitwitter University Hospitals pubmed.ncbi.nlm.nih.gov/34905760/

Testosterone replacement helps patients with #cirrhosis New study in CGH

Agree, I generally advise caution with the use of supplements. Combining tumeric and black pepper to "enhance" its effects could be very harmful. #Livertwitter #MedTwitter Here's a US case series from the DILI Network: sciencedirect.com/science/articl…

When do you consider liver transplantation in patients with ⬇️LOW MELD score? Very happy to work with my co-fellow #Noreensingh and transplant director Aldo J. Montano-Loza from the University of Alberta 🇨🇦. 🙂 👉 shorturl.at/M0JHK Liver Transplantation Journal (LTxJournal) #livertwitter aasld

Immune checkpoint inhibitor (ICI) before liver transplant ⬆️ rejection. 💡New study in HEPATOLOGY Journal reveals a 50-days washout period is optimal for safety, cutting rejection significantly. #livertwitter #HCC #immunotherapy #transplant

Save the date for the 11th annual MetroGI symposium in August! Great talks and fantastic speakers! our featured lineup for our non GI friends: will be updates on GERD management/evaluation, HCV treatment and noninvasive testing in liver disease. Please come, enjoy, and network!

Quite a shocking read about the state of organ allocation in the US. Thank you, The New York Times, for highting the issue. I hope that we can find a way to rebalance the system I was trained in. University Hospitals #Livertwitter nytimes.com/interactive/20…

Your liver is the foundation of your health. This #WorldLiverDay, let's care for it together one healthy choice at a time. #MASLD #FoodIsMedicine World Liver Day youtube.com/watch?v=e3YV5N…

Outstanding review of AAT deficiency in HEPATOLOGY Journal. Bookmarked this one as a reminder of: ✅️Genetics & Pathophysiology ✅️AAT phenotypes ✅️SZ phenotype and ⬆️ cancer risk ✅️Controversies with plasma-purified AAT Case Western/UH IM Chiefs CWRU-GI/Case Western GI Fellowship #livertwitter journals.lww.com/hepcomm/fullte…

May is Hepatitis Awareness Month, raising awareness of the importance of vaccination for hep A & hep B, testing for hep B & hep C, the availability of effective care & curative treatment, and the serious health consequences resulting from undiagnosed & untreated viral hepatitis.

SYMMETRY #efruxifermin study in compensated cirrhosis EASL Education #EASLCongress by Mazen Noureddin, MD, MHSc The upshot is shown below at wk 96 ITT 🔼 fibrosis 18% “Completer” 🔼 fibrosis 24% Improved NITs Reduced placebo adjusted BMD by 5%. No imbalance in fracture rate. #livertwitter

Important study in NEJM ❤️ seeing Mazen Noureddin, MD, MHSc front page! 😁for treatments to reverse #cirrhosis ⚠️careful not to over interpret negative phase 2b with *signals* 🧐everyone should learn about FGF21, a fascinating hormone at the intersection of liver metabolism and fibrogenesis

💊 DOACs in cirrhosis 🗣️ Cindy Pereira Portela (Lausanne) – #EASL2025 ✅ Child A/B: ok (⚠️ no rivaroxaban in B) 🚫 Child C: not recommended ⭐ Apixaban might be the winner — but more data needed 🧩 Case-by-case decision 🤝 Multidisciplinary approach is essential

This paper studies how parental alcohol use disorder and #liverdisease related mortality influence the risk and the outcomes of alcohol-associated #hepatitis in offspring. #LiverTransplant Vijay Shah Doug Simonetto, MD Hepatology Communications bit.ly/3SX9jS7

The June issue of the #RedJournal is here!   Explore this month's articles, including TWO new ACG Clinical Guidelines: Ulcerative Colitis & Crohn's Disease!   📕 amjgastro.com Millie Long Jasmohan Bajaj Andrew Moon Judy Trieu, MD, MPH